A Study of Buntanetap in Participants With PD
NCT07284784
This study is recruiting at 27 US sites in 21 states, according to its ClinicalTrials.gov record last updated .
Summary
This study will examine the long-term safety of buntanetap in participants with PD. This will be a 36-month open-label safety study. This study will be conducted with two cohorts. Cohort 1 will enroll via invitation only for PD participants who have previously participated in buntanetap clinical trials. Cohort 2 will be for PD participants who are receiving deep brain stimulation (DBS) treatment. Qualified participants will receive buntanetap 30mg QD after a screening period of up to 42 days.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Parkinson's Disease (PD)
- Deep Brain Stimulation
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2/3
- Ages
- 40 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Annovis Bio Inc.
- Last updated on ClinicalTrials.gov
- September 21, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- University of Alabama at Birmingham · Birmingham, AL
Arizona · 1
- Banner Sun Health Research Institute - Cleo Roberts Center for Clinical Research · Sun City, AZ
California · 1
- Parkinson's & Movement Disorder Institute (PMDI) - Orange County Office · Fountain Valley, CA
Colorado · 1
- Cenexel Rocky Mountain Clinical Research · Englewood, CO
Connecticut · 1
- New England Institute for Clinical Research (Ki Health Partners) · Stamford, CT
Florida · 6
- First Choice Neurology - Aventura Neurologic Associates · Aventura, FL
- Arrow Clinical Trials · Daytona Beach, FL
- Accel Clinical Sites-Georgia LLC dba Accel Research Sites-Lake Oconee CRU · DeLand, FL
- Renstar Medical Research · Ocala, FL
- University of South Florida (USF) - University of South Florida College of Medicine - Parkinson's Di · Tampa, FL
- Conquest Research · Winter Park, FL
Georgia · 1
- iResearch Atlanta · Decatur, GA
Indiana · 1
- Josephson Wallack Munshower Neurology, P.C. · Indianapolis, IN
Kansas · 1
- University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D · Kansas City, KS
Michigan · 1
- Quest Research Institute · Farmington Hills, MI
New York · 1
- Mount Sinai Hospital · New York, NY
North Carolina · 1
- Duke Department of Neurosurgery · Durham, NC
Ohio · 1
- The Ohio State University Wexner Medical Center · Columbus, OH
Oklahoma · 1
- The Movement Disorder Clinic of Oklahoma · Tulsa, OK
Pennsylvania · 1
- Abington Neurology · Willow Grove, PA
South Carolina · 1
- Medical University of South Carolina (MUSC) - The Murray Center for Research on Parkinson's Disease · Charleston, SC
Tennessee · 2
- Neurology Clinic, P.C. · Cordova, TN
- Veracity Neuroscience LLC · Memphis, TN
Texas · 1
- Central Texas Neurology · Round Rock, TX
Virginia · 1
- University of Virginia Health System (UVAHS) - Adult Neurology Clinic · Charlottesville, VA
Washington · 1
- Inland Northwest Research · Spokane, WA
Wisconsin · 1
- Medical College of Wisconsin · Milwaukee, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.